Triple chronotherapy (combined total sleep deprivation, sleep phase advance and bright light therapy) to reduce acute depressive and suicidal symptoms: a randomized controlled clinical trial

Study identification

• EU PAS number:
  EUPAS30637
• Study ID:
  50737
• Official title and acronym:
  Triple chronotherapy (combined total sleep deprivation, sleep phase advance and bright light therapy) to reduce acute depressive and suicidal symptoms: a randomized controlled clinical trial
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

ASST Santi Paolo e Carlo

Study timelines

Date when funding contract was signed

Planned:20/07/2018

Actual:20/07/2018

Study start date

Planned:03/12/2018

Actual:03/12/2018

Data analysis start date

Planned:01/04/2021

Date of interim report, if expected

Planned:30/06/2021

Date of final study report

Planned:01/06/2023

Sources of funding

Other

More details on funding

unfunded study

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable